ePRO

ePRO from Almac Delivers Unrivalled Patient Compliance

The Almac approach to ePRO is to provide services and solutions which offer flexibility to patients, sites and sponsors. By understanding the needs of the end users of the service, ePRO from Almac delivers:

For the Sponsor:

  • Solutions that are designed with the FDA Final ePRO guidance in mind
  • Unrivalled patient compliance rates which consistently exceed 90%
  • Cost-effective solutions for your study requirements
  • Customised compliance and data alerts for study personnel sent by email, fax, phone or text message
  • High quality ePRO data that can be used for a variety of purposes including the support of  regulatory submissions for new drugs, label changes and label claims, formulary/dossier submissions, marketing differentiation, and other commercial purposes

For the Site:

  • Automatic creation of best-fit visit schedules
  • Simple and intuitive visit management interface
  • Automated reminder notifications sent directly to patients by email, text message, or phone
  • Customised study notifications sent by email, fax, phone, or text message to site personnel

For the Patient:

  • A device agnostic approach to ePRO data collection, which puts the patient first, enabling them to switch between input modes during the course of your trial (e.g. phone, web)
  • Flexible real-world solutions, which maintain  patient engagement with your study
  • Automated patient reminders and motivational messages sent via email, phone, or text message to improve patient compliance

Almac Advantage

Customer Service

Almac’s customer service is consistently rated one of the highest in the industry by sites and sponsors. Our project teams go above and beyond to ensure that all users’ needs are met throughout the life of a trial.

Global Reach

Almac’s technology and services have been deployed globally since 1995 in over 80 countries and 60 languages.

User-Friendly Technology

Satisfied users are productive users. Almac is always looking for new ways to improve the user-friendliness of our technology.

Experience

Almac’s has conducted over 1600 clinical trials worldwide, involving 1.5 million patients at 100,000 sites in over 80 countries and 60 languages. Our clinical technologies’ client base includes approximately 250 firms, with several Top 50 biopharmaceutical firms and over 150 small and medium-sized companies.

Flash replacement image